351002-98-7

Basic information

• Product Name: 2 5-DIETHOXYBENZYL ALCOHOL 99
• Synonyms: 2 5-DIETHOXYBENZYL ALCOHOL 99
• CAS NO: 351002-98-7
• Molecular Formula: C₁₁H₁₆O₃
• Molecular Weight: 196.244
• Product Categories: Alcohols;C9 to C30;Oxygen Compounds;Building Blocks;C11 to C30+;Chemical Synthesis;Organic Building Blocks;Oxygen Compounds
• Mol File: 351002-98-7.mol
• Article Data: 2

Chemical Properties

• Melting Point: 50-54 °C(lit.)
• Boiling Point: 316.8°C at 760 mmHg
• Flash Point: >230 °F
• Appearance: /
• Density: 1.064g/cm³
• Vapor Pressure: 0.000169mmHg at 25°C
• Refractive Index: 1.512
• PKA: 14.18±0.10(Predicted)
• CAS DataBase Reference: 2 5-DIETHOXYBENZYL ALCOHOL 99(CAS DataBase Reference)
• NIST Chemistry Reference: 2 5-DIETHOXYBENZYL ALCOHOL 99(351002-98-7)
• EPA Substance Registry System: 2 5-DIETHOXYBENZYL ALCOHOL 99(351002-98-7)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 351002-98-7(Hazardous Substances Data)

Usage

Physical state

Pale yellow liquid

Odor

Strong aromatic

Functional groups

Two ethoxy groups attached to a benzene ring

Common uses

Reagent in organic synthesis, pharmaceutical applications, production of perfumes and industrial products

Properties

Antimicrobial, antioxidant

Value in cosmetic and personal care products

Ingredient

Role in research and development

Unique structure and reactivity

InChI:InChI=1/C11H16O3/c1-3-13-10-5-6-11(14-4-2)9(7-10)8-12/h5-7,12H,3-4,8H2,1-2H3

Upstream product

• 4686-98-0 2,5-diethoxybenzaldehyde 
• 122-95-2 1,4-diethoxybenzene 
• 1194-98-5 2,5-Dihydroxybenzaldehyde 

Downstream Products

• 103861-41-2 1,4-diethoxy-2-chloromethyl-benzene 

Relevant articles and documents

In vitro study and structure-activity relationship analysis of stilbenoid derivatives as powerful vasorelaxants: Discovery of new lead compound

The development of vasorelaxant as the antihypertensive drug is important as it produces a rapid and direct relaxation effect on the blood vessel muscles. Resveratrol (RV), as the most widely studied stilbenoid and the lead compound, inducing the excellent vasorelaxation effect through the multiple signalling pathways. In this study, the in vitro vascular response of the synthesized trans-stilbenoid derivatives, SB 1-8e were primarily evaluated by employing the phenylephrine (PE)-precontracted endothelium-intact isolated aortic rings. Herein we report trans-3,4,4′-trihydroxystilbene (SB 8b) exhibited surprisingly more than 2-fold improvement to the maximal relaxation (Rmax) of RV. This article also highlights the characterization of the aromatic protons in terms of their unique splitting patterns in 1H NMR.